2023 US-Japan Global Health Dialogue

September 18, 2023
Washington DC

JCIE and the National Academy of Medicine brought together around 20 American and Japanese officials and experts in Washington DC for the 2023 US-Japan Global Health Dialogue. The discussion built on the global health outcomes of the May 2023 G7 Summit in Hiroshima, Japan, and offered an opportunity to examine potential areas of US-Japan collaboration on how to advance resilient, equitable, and sustainable universal health coverage (UHC); how to ensure timely and equitable access to medical countermeasures (MCMs) in times of crises; and how to ensure surge capacity to respond to future pandemics.

This meeting was held as part of JCIE’s US-Japan Global Health Dialogue, an initiative launched in 2017 to foster continued collaboration between the US and Japan on salient global health issues. 

2023 US-Japan Global Health Dialogue

Welcoming Remarks

KEIZO TAKEMI, Minister of Health, Labour and Welfare of Japan

Session 1: Advancing more resilient, equitable, and sustainable UHC through strengthening health systems

ATUL GAWANDE, Assistant for Global Health, US Agency for International Development (USAID) 

KEIZO TAKEMI

Session 2: How to ensure timely and equitable access to MCMs and other medical tools to tackle health threats

DAWN O’CONNELL, Assistant Secretary for Preparedness and Response, U.S. Department
of Health and Human Services

OSAMU KUNII, CEO & Executive Director, Global Health Innovative Technology Fund

Session 3: How to ensure surge capacity to respond to future pandemics in terms of financing and workforce (surge financing and emergency workforce)

PAMELA HAMAMOTO, U.S. Chief Negotiator for the Pandemic Accord Negotiations,
Bureau of Global Health Security and Diplomacy, U.S. State Department

HIDEAKI IMAMURA, World Bank Group Executive Director representing Japan

Toast

TAMAKI TSUKADA, Deputy Chief of Mission, U.S. Embassy of Japan

Closing Remarks

VICTOR DZAU, U.S. National Academy of Medicine

CAYA LEWIS ATKINS, Chief Advisor for Policy and Strategy, Office of Global Affairs, US Department of Health and Human Services

SHYAM BISHEN, Head, Centre for Health and Healthcare, World Economic Forum

VICTOR DZAU, President, US National Academy of Medicine

SATOSHI EZOE, Director, Global Health Strategy Division, International Cooperation Bureau, Ministry of Foreign Affairs, Japan

ATUL GAWANDE, Assistant Administrator for Global Health, U.S. Agency for International Development

PAMELA HAMAMOTO, US Chief Negotiator for the Pandemic Accord Negotiations, Bureau of Global Health Security and Diplomacy, US State Department

RICHARD HATCHETT, Chief Executive Officer, Coalition for Epidemic Preparedness Innovations

EIJI HINOSHITA, Assistant Minister for Global Health and Welfare, Japanese Ministry of Health, Labour and Welfare

HIDEAKI IMAMURA, World Bank Group Executive Director representing Japan

OSAMU KUNII, Chief Executive Officer & Executive Director, Global Health Innovative Technology Fund

MAUREEN LICHTVELD, Dean, School of Public Health, University of Pittsburgh

JEANNE M. MARRAZZO, Director, Division of Infectious Diseases, University of Alabama at Birmingham; Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health (incoming)

DAWN O’CONNELL, Assistant Secretary for Preparedness and Response, US Department of Health and Human Services

ANDREA PALM, Deputy Secretary, US Department of Health and Human Services

CARLOS DEL RIO, Executive Associate Dean, Emory School of Medicine & Grady Health System; International Secretary, National Academy of Medicine

CECILIA MUNDACA SHAH, Director, Global Health, UN Foundation

KEIZO TAKEMI, Minister of Health, Labour and Welfare of Japan

TAMAKI TSUKADA, Deputy Chief of Mission, Embassy of Japan in the United States

MONIQUE VLEDDER, Practice Manager for the Global Health, Nutrition and Population, World Bank

HOWARD ZUCKER, Deputy Director for Global Health, US Centers for Disease Control and Prevention

2023 US-Japan Global Health Dialogue